

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.33585736 |
| 2 | mannose metabolic process (GO:0006013) | 4.67822703 |
| 3 | lysine catabolic process (GO:0006554) | 4.60305479 |
| 4 | lysine metabolic process (GO:0006553) | 4.60305479 |
| 5 | regulation of cholesterol homeostasis (GO:2000188) | 4.40578460 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 4.31632615 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.21146228 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 4.21146228 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.04261191 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 4.04261191 |
| 11 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.01486892 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.95217865 |
| 13 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.90776083 |
| 14 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.86807023 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.78965987 |
| 16 | negative regulation of fibrinolysis (GO:0051918) | 3.77426588 |
| 17 | kynurenine metabolic process (GO:0070189) | 3.69096757 |
| 18 | glyoxylate metabolic process (GO:0046487) | 3.65488492 |
| 19 | negative regulation of sterol transport (GO:0032372) | 3.62075173 |
| 20 | negative regulation of cholesterol transport (GO:0032375) | 3.62075173 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.61082778 |
| 22 | positive regulation of histone deacetylation (GO:0031065) | 3.60938482 |
| 23 | 2-oxoglutarate metabolic process (GO:0006103) | 3.60247878 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 3.58986900 |
| 25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.56640835 |
| 26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.55663909 |
| 27 | negative regulation of cell killing (GO:0031342) | 3.55663909 |
| 28 | cysteine metabolic process (GO:0006534) | 3.55477096 |
| 29 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.52361116 |
| 30 | aromatic amino acid family catabolic process (GO:0009074) | 3.46499422 |
| 31 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.46023412 |
| 32 | urea cycle (GO:0000050) | 3.45864021 |
| 33 | urea metabolic process (GO:0019627) | 3.45864021 |
| 34 | response to muramyl dipeptide (GO:0032495) | 3.41755019 |
| 35 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.41527676 |
| 36 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.41402919 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 3.39986221 |
| 38 | fatty acid transmembrane transport (GO:1902001) | 3.39620985 |
| 39 | aspartate family amino acid catabolic process (GO:0009068) | 3.39196627 |
| 40 | carnitine shuttle (GO:0006853) | 3.36690193 |
| 41 | thymic T cell selection (GO:0045061) | 3.31282686 |
| 42 | regulation of fatty acid oxidation (GO:0046320) | 3.29548127 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 3.29367816 |
| 44 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.26889186 |
| 45 | protein carboxylation (GO:0018214) | 3.26879176 |
| 46 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.26879176 |
| 47 | apoptotic process involved in morphogenesis (GO:0060561) | 3.25622208 |
| 48 | negative regulation of cell size (GO:0045792) | 3.23246980 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.22424132 |
| 50 | maternal placenta development (GO:0001893) | 3.19433093 |
| 51 | 4-hydroxyproline metabolic process (GO:0019471) | 3.18992045 |
| 52 | complement activation, alternative pathway (GO:0006957) | 3.17362357 |
| 53 | regulation of cholesterol esterification (GO:0010872) | 3.17161422 |
| 54 | positive regulation of lipid catabolic process (GO:0050996) | 3.16787680 |
| 55 | NIK/NF-kappaB signaling (GO:0038061) | 3.15855493 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 3.15384966 |
| 57 | positive regulation of fatty acid oxidation (GO:0046321) | 3.15362696 |
| 58 | fatty acid beta-oxidation (GO:0006635) | 3.14352175 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 3.14176637 |
| 60 | regulation of ARF GTPase activity (GO:0032312) | 3.13456560 |
| 61 | acetyl-CoA metabolic process (GO:0006084) | 3.12852498 |
| 62 | nitrogen cycle metabolic process (GO:0071941) | 3.12680142 |
| 63 | valine metabolic process (GO:0006573) | 3.11370792 |
| 64 | regulation of fibrinolysis (GO:0051917) | 3.10120922 |
| 65 | low-density lipoprotein particle clearance (GO:0034383) | 3.08031403 |
| 66 | bile acid biosynthetic process (GO:0006699) | 3.07818808 |
| 67 | response to laminar fluid shear stress (GO:0034616) | 3.06906065 |
| 68 | serine family amino acid catabolic process (GO:0009071) | 3.05959059 |
| 69 | phospholipid efflux (GO:0033700) | 3.04843231 |
| 70 | high-density lipoprotein particle remodeling (GO:0034375) | 3.04144304 |
| 71 | glutamate metabolic process (GO:0006536) | 3.03719519 |
| 72 | modulation by symbiont of host cellular process (GO:0044068) | 3.03624097 |
| 73 | indole-containing compound catabolic process (GO:0042436) | 3.01444798 |
| 74 | indolalkylamine catabolic process (GO:0046218) | 3.01444798 |
| 75 | tryptophan catabolic process (GO:0006569) | 3.01444798 |
| 76 | regulation of extracellular matrix disassembly (GO:0010715) | 2.98963699 |
| 77 | negative regulation of lipid transport (GO:0032369) | 2.98748649 |
| 78 | ethanol oxidation (GO:0006069) | 2.98554123 |
| 79 | modulation by virus of host process (GO:0019054) | 2.98330324 |
| 80 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.98261242 |
| 81 | homocysteine metabolic process (GO:0050667) | 2.97863169 |
| 82 | detection of bacterium (GO:0016045) | 2.96982639 |
| 83 | tricarboxylic acid metabolic process (GO:0072350) | 2.96807581 |
| 84 | regulation of cholesterol storage (GO:0010885) | 2.96600798 |
| 85 | protein-lipid complex assembly (GO:0065005) | 2.94605492 |
| 86 | regulation of protein activation cascade (GO:2000257) | 2.94365074 |
| 87 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.94328805 |
| 88 | positive regulation by symbiont of host defense response (GO:0052509) | 2.91753429 |
| 89 | modulation by symbiont of host defense response (GO:0052031) | 2.91753429 |
| 90 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.91753429 |
| 91 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.91753429 |
| 92 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.91753429 |
| 93 | modulation by symbiont of host immune response (GO:0052553) | 2.91753429 |
| 94 | germinal center formation (GO:0002467) | 2.90615348 |
| 95 | carnitine transport (GO:0015879) | 2.90252616 |
| 96 | amino-acid betaine transport (GO:0015838) | 2.90252616 |
| 97 | semaphorin-plexin signaling pathway (GO:0071526) | 2.90049811 |
| 98 | fatty acid oxidation (GO:0019395) | 2.89818217 |
| 99 | response to peptidoglycan (GO:0032494) | 2.87546318 |
| 100 | detection of other organism (GO:0098543) | 2.86474095 |
| 101 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.84094986 |
| 102 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.83475727 |
| 103 | regulation of triglyceride metabolic process (GO:0090207) | 2.83308853 |
| 104 | lipid oxidation (GO:0034440) | 2.82280359 |
| 105 | carnitine transmembrane transport (GO:1902603) | 2.81036651 |
| 106 | activation of MAPKKK activity (GO:0000185) | 2.79588905 |
| 107 | regulation of complement activation (GO:0030449) | 2.78598990 |
| 108 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.78483290 |
| 109 | regulation of early endosome to late endosome transport (GO:2000641) | 2.77832211 |
| 110 | carnitine metabolic process (GO:0009437) | 2.77378110 |
| 111 | fatty acid catabolic process (GO:0009062) | 2.77268330 |
| 112 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.76826282 |
| 113 | response to mercury ion (GO:0046689) | 2.76670600 |
| 114 | plasma lipoprotein particle assembly (GO:0034377) | 2.76507812 |
| 115 | alpha-amino acid catabolic process (GO:1901606) | 2.76380030 |
| 116 | activation of JUN kinase activity (GO:0007257) | 2.74956624 |
| 117 | phospholipid homeostasis (GO:0055091) | 2.74284674 |
| 118 | macrophage activation involved in immune response (GO:0002281) | 2.73454975 |
| 119 | acylglycerol homeostasis (GO:0055090) | 2.72992314 |
| 120 | triglyceride homeostasis (GO:0070328) | 2.72992314 |
| 121 | reverse cholesterol transport (GO:0043691) | 2.72796235 |
| 122 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.72729212 |
| 123 | short-chain fatty acid metabolic process (GO:0046459) | 2.72659275 |
| 124 | activation of Rac GTPase activity (GO:0032863) | 2.71879870 |
| 125 | T cell selection (GO:0045058) | 2.69010142 |
| 126 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.68973377 |
| 127 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.68973377 |
| 128 | tryptophan metabolic process (GO:0006568) | 2.68659890 |
| 129 | adherens junction assembly (GO:0034333) | 2.67687642 |
| 130 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.66764715 |
| 131 | cholesterol homeostasis (GO:0042632) | 2.66186059 |
| 132 | sterol homeostasis (GO:0055092) | 2.66124143 |
| 133 | monocarboxylic acid catabolic process (GO:0072329) | 2.66063320 |
| 134 | regulation of gamma-delta T cell activation (GO:0046643) | 2.65731187 |
| 135 | protein localization to endosome (GO:0036010) | 2.65148796 |
| 136 | drug catabolic process (GO:0042737) | 2.65142502 |
| 137 | glycine metabolic process (GO:0006544) | 2.64294592 |
| 138 | stress fiber assembly (GO:0043149) | 2.63849078 |
| 139 | cellular ketone body metabolic process (GO:0046950) | 2.62752361 |
| 140 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.62721692 |
| 141 | cellular amino acid catabolic process (GO:0009063) | 2.62599439 |
| 142 | positive thymic T cell selection (GO:0045059) | 2.62291745 |
| 143 | bile acid metabolic process (GO:0008206) | 2.61820306 |
| 144 | leukocyte aggregation (GO:0070486) | 2.59706231 |
| 145 | focal adhesion assembly (GO:0048041) | 2.59580843 |
| 146 | cell-substrate adherens junction assembly (GO:0007045) | 2.59580843 |
| 147 | apoptotic cell clearance (GO:0043277) | 2.58893018 |
| 148 | signal complex assembly (GO:0007172) | 2.57495864 |
| 149 | barbed-end actin filament capping (GO:0051016) | 2.56906450 |
| 150 | negative regulation of myotube differentiation (GO:0010832) | 2.56304679 |
| 151 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.55145151 |
| 152 | regulation of ARF protein signal transduction (GO:0032012) | 2.54920680 |
| 153 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.52725462 |
| 154 | embryonic process involved in female pregnancy (GO:0060136) | 2.51401006 |
| 155 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.51351916 |
| 156 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.49874950 |
| 157 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.49490585 |
| 158 | regulation of histone H3-K27 methylation (GO:0061085) | 2.48365821 |
| 159 | histone H4 deacetylation (GO:0070933) | 2.47974860 |
| 160 | positive regulation of receptor recycling (GO:0001921) | 2.47617925 |
| 161 | regulation of leukocyte degranulation (GO:0043300) | 2.47393581 |
| 162 | cellular response to virus (GO:0098586) | 2.46479593 |
| 163 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.46404477 |
| 164 | positive regulation of protein deacetylation (GO:0090312) | 2.46207849 |
| 165 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.43591602 |
| 166 | negative regulation of viral release from host cell (GO:1902187) | 2.43541995 |
| 167 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.42059363 |
| 168 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.40939666 |
| 169 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.39694704 |
| 170 | positive regulation of Rap GTPase activity (GO:0032854) | 2.39625716 |
| 171 | detection of external biotic stimulus (GO:0098581) | 2.38894628 |
| 172 | cell-cell junction maintenance (GO:0045217) | 2.37464964 |
| 173 | pinocytosis (GO:0006907) | 2.37196553 |
| 174 | negative thymic T cell selection (GO:0045060) | 2.36012613 |
| 175 | COPI coating of Golgi vesicle (GO:0048205) | 2.35695997 |
| 176 | Golgi transport vesicle coating (GO:0048200) | 2.35695997 |
| 177 | negative regulation of fatty acid transport (GO:2000192) | 2.35678198 |
| 178 | negative regulation of granulocyte differentiation (GO:0030853) | 2.34680211 |
| 179 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.33440768 |
| 180 | protein retention in ER lumen (GO:0006621) | 2.32612270 |
| 181 | regulation of monocyte differentiation (GO:0045655) | 2.31752401 |
| 182 | regulation of necroptotic process (GO:0060544) | 2.31678264 |
| 183 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.31255802 |
| 184 | regulation of extracellular matrix organization (GO:1903053) | 2.30783896 |
| 185 | cell-substrate junction assembly (GO:0007044) | 2.30747637 |
| 186 | positive T cell selection (GO:0043368) | 2.30331446 |
| 187 | positive regulation of protein dephosphorylation (GO:0035307) | 2.29409999 |
| 188 | regulation of necrotic cell death (GO:0010939) | 2.29199763 |
| 189 | retrograde transport, endosome to Golgi (GO:0042147) | 2.28367089 |
| 190 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.28084818 |
| 191 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.28043534 |
| 192 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.27554144 |
| 193 | tolerance induction (GO:0002507) | 2.25991012 |
| 194 | response to type I interferon (GO:0034340) | 2.25198096 |
| 195 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.23533606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.21962276 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.00664503 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.81330573 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.66537598 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.95962345 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.70122459 |
| 7 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.56294774 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.50155364 |
| 9 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.37497214 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.35332547 |
| 11 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.33787452 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.21652854 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.20878916 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.19442341 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.19279041 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.19161029 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.18221848 |
| 18 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.09930342 |
| 19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.07684354 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.06456613 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.02833486 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01993871 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01536509 |
| 24 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.95548424 |
| 25 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.88834916 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.88424255 |
| 27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.72305397 |
| 28 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.64480908 |
| 29 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.61907344 |
| 30 | KDM2B_26808549_Chip-Seq_K562_Human | 1.61557708 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57575495 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.54414489 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.53562536 |
| 34 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52308893 |
| 35 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.50968484 |
| 36 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.50926747 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.48955378 |
| 38 | P68_20966046_ChIP-Seq_HELA_Human | 1.48503117 |
| 39 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.46675052 |
| 40 | ATF3_27146783_Chip-Seq_COLON_Human | 1.46089626 |
| 41 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.45639594 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44630338 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41998903 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41439771 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40943131 |
| 46 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.38523615 |
| 47 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.38409481 |
| 48 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.37270028 |
| 49 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.36931984 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36548993 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36263054 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.35266229 |
| 53 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.29565005 |
| 54 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.29565005 |
| 55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29202658 |
| 56 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.28252215 |
| 57 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28202836 |
| 58 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.28106543 |
| 59 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27577672 |
| 60 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.27321213 |
| 61 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27316450 |
| 62 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26697258 |
| 63 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26584440 |
| 64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26318569 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23429196 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22829143 |
| 67 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22137004 |
| 68 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.20573254 |
| 69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20362605 |
| 70 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19810304 |
| 71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19543078 |
| 72 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19331752 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19324576 |
| 74 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19150384 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18281693 |
| 76 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.17672986 |
| 77 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17362624 |
| 78 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.16975687 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14217886 |
| 80 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13677766 |
| 81 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13638817 |
| 82 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.13585269 |
| 83 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13551358 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13392613 |
| 85 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.12988441 |
| 86 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.12790066 |
| 87 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12758543 |
| 88 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12015312 |
| 89 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.11517431 |
| 90 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11357053 |
| 91 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.10997946 |
| 92 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.10848090 |
| 93 | MAF_26560356_Chip-Seq_TH2_Human | 1.10229103 |
| 94 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09728727 |
| 95 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09425588 |
| 96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09273904 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09091374 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09003414 |
| 99 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08732699 |
| 100 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.07935137 |
| 101 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.07544467 |
| 102 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06850979 |
| 103 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06550052 |
| 104 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06445487 |
| 105 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05931742 |
| 106 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.03076188 |
| 107 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02218409 |
| 108 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02036393 |
| 109 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01210598 |
| 110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01091898 |
| 111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00781046 |
| 112 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00606870 |
| 113 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.00264463 |
| 114 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99816106 |
| 115 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.99779676 |
| 116 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99433496 |
| 117 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.98759314 |
| 118 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98589364 |
| 119 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.97964063 |
| 120 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.97433831 |
| 121 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96161059 |
| 122 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95377495 |
| 123 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95351015 |
| 124 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.94640382 |
| 125 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.92999842 |
| 126 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92657056 |
| 127 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92467027 |
| 128 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.91906044 |
| 129 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.90939122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.63828393 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.45204116 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.95892684 |
| 4 | MP0009840_abnormal_foam_cell | 3.44186987 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.21445088 |
| 6 | MP0005365_abnormal_bile_salt | 3.10787377 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.82161881 |
| 8 | MP0003252_abnormal_bile_duct | 2.74207441 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.54567119 |
| 10 | MP0008260_abnormal_autophagy | 2.47040294 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.37990029 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.22713020 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.19780787 |
| 14 | MP0005083_abnormal_biliary_tract | 2.19344056 |
| 15 | MP0003303_peritoneal_inflammation | 2.11809825 |
| 16 | MP0004130_abnormal_muscle_cell | 2.05992588 |
| 17 | MP0004185_abnormal_adipocyte_glucose | 1.90809099 |
| 18 | MP0005332_abnormal_amino_acid | 1.87172732 |
| 19 | MP0008961_abnormal_basal_metabolism | 1.86933032 |
| 20 | MP0003763_abnormal_thymus_physiology | 1.84902955 |
| 21 | MP0005666_abnormal_adipose_tissue | 1.81064128 |
| 22 | MP0000678_abnormal_parathyroid_gland | 1.72423598 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 1.71477478 |
| 24 | MP0000751_myopathy | 1.70766019 |
| 25 | MP0005025_abnormal_response_to | 1.69127351 |
| 26 | MP0000609_abnormal_liver_physiology | 1.68824782 |
| 27 | MP0002419_abnormal_innate_immunity | 1.68666416 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.68593207 |
| 29 | MP0000858_altered_metastatic_potential | 1.68143592 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.64643222 |
| 31 | MP0005670_abnormal_white_adipose | 1.64275228 |
| 32 | MP0001790_abnormal_immune_system | 1.62067892 |
| 33 | MP0005387_immune_system_phenotype | 1.62067892 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.60474679 |
| 35 | MP0005409_darkened_coat_color | 1.57899618 |
| 36 | MP0001835_abnormal_antigen_presentation | 1.57815581 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.53570466 |
| 38 | MP0002118_abnormal_lipid_homeostasis | 1.51405081 |
| 39 | MP0005375_adipose_tissue_phenotype | 1.51303638 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.50898892 |
| 41 | MP0001348_abnormal_lacrimal_gland | 1.47106569 |
| 42 | MP0001800_abnormal_humoral_immune | 1.46433881 |
| 43 | MP0004087_abnormal_muscle_fiber | 1.45497979 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.44143478 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.43730875 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.43478043 |
| 47 | MP0001873_stomach_inflammation | 1.42926550 |
| 48 | MP0009278_abnormal_bone_marrow | 1.41089101 |
| 49 | MP0003724_increased_susceptibility_to | 1.40842591 |
| 50 | MP0005330_cardiomyopathy | 1.39065355 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.38293936 |
| 52 | MP0001666_abnormal_nutrient_absorption | 1.37474150 |
| 53 | MP0002933_joint_inflammation | 1.37302619 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.33573626 |
| 55 | MP0002723_abnormal_immune_serum | 1.33472882 |
| 56 | MP0001819_abnormal_immune_cell | 1.32982773 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.32665360 |
| 58 | MP0002452_abnormal_antigen_presenting | 1.30736827 |
| 59 | MP0005076_abnormal_cell_differentiation | 1.29924256 |
| 60 | MP0000747_muscle_weakness | 1.28881178 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 1.28809700 |
| 62 | MP0009643_abnormal_urine_homeostasis | 1.28362065 |
| 63 | MP0002249_abnormal_larynx_morphology | 1.28011857 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 1.25648300 |
| 65 | MP0002796_impaired_skin_barrier | 1.23762602 |
| 66 | MP0004084_abnormal_cardiac_muscle | 1.22643632 |
| 67 | MP0010630_abnormal_cardiac_muscle | 1.22331831 |
| 68 | MP0002405_respiratory_system_inflammati | 1.18090751 |
| 69 | MP0000733_abnormal_muscle_development | 1.17882908 |
| 70 | MP0004510_myositis | 1.16769666 |
| 71 | MP0010352_gastrointestinal_tract_polyps | 1.16074786 |
| 72 | MP0002269_muscular_atrophy | 1.15255780 |
| 73 | MP0000003_abnormal_adipose_tissue | 1.14418422 |
| 74 | MP0002398_abnormal_bone_marrow | 1.13795813 |
| 75 | MP0005275_abnormal_skin_tensile | 1.13520436 |
| 76 | MP0001545_abnormal_hematopoietic_system | 1.13483491 |
| 77 | MP0005397_hematopoietic_system_phenotyp | 1.13483491 |
| 78 | MP0003195_calcinosis | 1.12857045 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.10012060 |
| 80 | MP0000716_abnormal_immune_system | 1.09806413 |
| 81 | MP0003279_aneurysm | 1.08671359 |
| 82 | MP0003646_muscle_fatigue | 1.08267371 |
| 83 | MP0002971_abnormal_brown_adipose | 1.07277096 |
| 84 | MP0006082_CNS_inflammation | 1.06471132 |
| 85 | MP0003329_amyloid_beta_deposits | 1.06192948 |
| 86 | MP0005671_abnormal_response_to | 1.05773402 |
| 87 | MP0004019_abnormal_vitamin_homeostasis | 1.05654363 |
| 88 | MP0001849_ear_inflammation | 1.05375056 |
| 89 | MP0000598_abnormal_liver_morphology | 1.04191197 |
| 90 | MP0005451_abnormal_body_composition | 1.04147697 |
| 91 | MP0004381_abnormal_hair_follicle | 1.03448047 |
| 92 | MP0000604_amyloidosis | 1.03225170 |
| 93 | MP0009785_altered_susceptibility_to | 1.02665255 |
| 94 | MP0005023_abnormal_wound_healing | 1.02111194 |
| 95 | MP0000703_abnormal_thymus_morphology | 1.00258742 |
| 96 | MP0000749_muscle_degeneration | 0.99685697 |
| 97 | MP0001853_heart_inflammation | 0.98255606 |
| 98 | MP0000750_abnormal_muscle_regeneration | 0.97504735 |
| 99 | MP0001958_emphysema | 0.95250592 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.95225685 |
| 101 | MP0005390_skeleton_phenotype | 0.95153899 |
| 102 | MP0002148_abnormal_hypersensitivity_rea | 0.95041001 |
| 103 | MP0002429_abnormal_blood_cell | 0.94549667 |
| 104 | MP0003828_pulmonary_edema | 0.94487327 |
| 105 | MP0001845_abnormal_inflammatory_respons | 0.94010891 |
| 106 | MP0004036_abnormal_muscle_relaxation | 0.93295538 |
| 107 | MP0003690_abnormal_glial_cell | 0.92760136 |
| 108 | MP0001851_eye_inflammation | 0.91507342 |
| 109 | MP0003866_abnormal_defecation | 0.91110458 |
| 110 | MP0002722_abnormal_immune_system | 0.90036137 |
| 111 | MP0005501_abnormal_skin_physiology | 0.89091448 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.88699221 |
| 113 | MP0003075_altered_response_to | 0.88180552 |
| 114 | MP0000759_abnormal_skeletal_muscle | 0.87813276 |
| 115 | MP0005623_abnormal_meninges_morphology | 0.87556191 |
| 116 | MP0005058_abnormal_lysosome_morphology | 0.87052295 |
| 117 | MP0003183_abnormal_peptide_metabolism | 0.86474312 |
| 118 | MP0004808_abnormal_hematopoietic_stem | 0.86460237 |
| 119 | MP0003453_abnormal_keratinocyte_physiol | 0.86219607 |
| 120 | MP0003045_fibrosis | 0.86127727 |
| 121 | MP0002060_abnormal_skin_morphology | 0.84289742 |
| 122 | MP0004947_skin_inflammation | 0.83406417 |
| 123 | MP0010368_abnormal_lymphatic_system | 0.83368259 |
| 124 | MP0000685_abnormal_immune_system | 0.82652208 |
| 125 | MP0002254_reproductive_system_inflammat | 0.81862995 |
| 126 | MP0003283_abnormal_digestive_organ | 0.81132270 |
| 127 | MP0009384_cardiac_valve_regurgitation | 0.80275001 |
| 128 | MP0003091_abnormal_cell_migration | 0.79667800 |
| 129 | MP0008469_abnormal_protein_level | 0.79329456 |
| 130 | MP0000490_abnormal_crypts_of | 0.79097648 |
| 131 | MP0002089_abnormal_postnatal_growth/wei | 0.78736441 |
| 132 | MP0003448_altered_tumor_morphology | 0.78351059 |
| 133 | MP0005385_cardiovascular_system_phenoty | 0.78151728 |
| 134 | MP0001544_abnormal_cardiovascular_syste | 0.78151728 |
| 135 | MP0002136_abnormal_kidney_physiology | 0.76935095 |
| 136 | MP0006138_congestive_heart_failure | 0.75833302 |
| 137 | MP0009931_abnormal_skin_appearance | 0.75468917 |
| 138 | MP0001663_abnormal_digestive_system | 0.75464598 |
| 139 | MP0008775_abnormal_heart_ventricle | 0.75341927 |
| 140 | MP0009053_abnormal_anal_canal | 0.74955031 |
| 141 | MP0003656_abnormal_erythrocyte_physiolo | 0.74910725 |
| 142 | MP0001756_abnormal_urination | 0.74055127 |
| 143 | MP0000681_abnormal_thyroid_gland | 0.73445301 |
| 144 | MP0009115_abnormal_fat_cell | 0.72492316 |
| 145 | MP0004264_abnormal_extraembryonic_tissu | 0.72300453 |
| 146 | MP0003436_decreased_susceptibility_to | 0.71747411 |
| 147 | MP0005334_abnormal_fat_pad | 0.70917749 |
| 148 | MP0004858_abnormal_nervous_system | 0.69219960 |
| 149 | MP0000767_abnormal_smooth_muscle | 0.68787376 |
| 150 | MP0002970_abnormal_white_adipose | 0.68677646 |
| 151 | MP0002106_abnormal_muscle_physiology | 0.68599367 |
| 152 | MP0002128_abnormal_blood_circulation | 0.67599263 |
| 153 | MP0000013_abnormal_adipose_tissue | 0.67530735 |
| 154 | MP0005464_abnormal_platelet_physiology | 0.65999237 |
| 155 | MP0004272_abnormal_basement_membrane | 0.65934539 |
| 156 | MP0009672_abnormal_birth_weight | 0.64057843 |
| 157 | MP0002909_abnormal_adrenal_gland | 0.63807856 |
| 158 | MP0005166_decreased_susceptibility_to | 0.62368576 |
| 159 | MP0002078_abnormal_glucose_homeostasis | 0.60633131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.47434665 |
| 2 | Xanthomatosis (HP:0000991) | 3.91463759 |
| 3 | Obstructive sleep apnea (HP:0002870) | 3.63092329 |
| 4 | Eczematoid dermatitis (HP:0000976) | 3.52389673 |
| 5 | Cerebral aneurysm (HP:0004944) | 3.19802066 |
| 6 | Broad face (HP:0000283) | 3.13899031 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.08677924 |
| 8 | Complement deficiency (HP:0004431) | 3.05639948 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.98216532 |
| 10 | Abnormality of the Achilles tendon (HP:0005109) | 2.90170181 |
| 11 | Protrusio acetabuli (HP:0003179) | 2.85773034 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 2.84990483 |
| 13 | Ketosis (HP:0001946) | 2.82502563 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 2.82379181 |
| 15 | Dysostosis multiplex (HP:0000943) | 2.72612164 |
| 16 | Increased connective tissue (HP:0009025) | 2.72491760 |
| 17 | Hyperammonemia (HP:0001987) | 2.71553436 |
| 18 | Myoglobinuria (HP:0002913) | 2.64664681 |
| 19 | Myocardial infarction (HP:0001658) | 2.64632426 |
| 20 | Increased IgE level (HP:0003212) | 2.64580430 |
| 21 | Achilles tendon contracture (HP:0001771) | 2.62895449 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.60957849 |
| 23 | Hyporeflexia of lower limbs (HP:0002600) | 2.60570769 |
| 24 | Cellulitis (HP:0100658) | 2.59364210 |
| 25 | Colitis (HP:0002583) | 2.57351614 |
| 26 | Distal lower limb amyotrophy (HP:0008944) | 2.57294742 |
| 27 | Distal upper limb amyotrophy (HP:0007149) | 2.57274079 |
| 28 | Upper limb amyotrophy (HP:0009129) | 2.57274079 |
| 29 | Abnormality of complement system (HP:0005339) | 2.55639062 |
| 30 | Cervical subluxation (HP:0003308) | 2.53454404 |
| 31 | Polycythemia (HP:0001901) | 2.49921549 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 2.48122876 |
| 33 | Hyperglycinuria (HP:0003108) | 2.47284454 |
| 34 | Broad metatarsal (HP:0001783) | 2.43622086 |
| 35 | Mitral valve prolapse (HP:0001634) | 2.40245907 |
| 36 | Stridor (HP:0010307) | 2.39589571 |
| 37 | Right ventricular cardiomyopathy (HP:0011663) | 2.39587973 |
| 38 | Hyperacusis (HP:0010780) | 2.36085891 |
| 39 | J-shaped sella turcica (HP:0002680) | 2.34739675 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.33571323 |
| 41 | Shallow orbits (HP:0000586) | 2.32758045 |
| 42 | Lymphangioma (HP:0100764) | 2.32266217 |
| 43 | Difficulty climbing stairs (HP:0003551) | 2.32132653 |
| 44 | Ketoacidosis (HP:0001993) | 2.31991617 |
| 45 | Back pain (HP:0003418) | 2.31442087 |
| 46 | Difficulty running (HP:0009046) | 2.30568884 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.30314246 |
| 48 | Vertebral compression fractures (HP:0002953) | 2.30171164 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 2.29975351 |
| 50 | Emphysema (HP:0002097) | 2.24549206 |
| 51 | Sudden death (HP:0001699) | 2.23281823 |
| 52 | Systemic lupus erythematosus (HP:0002725) | 2.23113332 |
| 53 | Premature rupture of membranes (HP:0001788) | 2.22093325 |
| 54 | Mucopolysacchariduria (HP:0008155) | 2.21495595 |
| 55 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.21495595 |
| 56 | Abnormality of glycine metabolism (HP:0010895) | 2.21303166 |
| 57 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.21303166 |
| 58 | Exercise-induced myalgia (HP:0003738) | 2.20839587 |
| 59 | Gastrointestinal inflammation (HP:0004386) | 2.20525888 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.20472748 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18933601 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18933601 |
| 63 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18933601 |
| 64 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.18734978 |
| 65 | Recurrent bacterial skin infections (HP:0005406) | 2.18717442 |
| 66 | Aneurysm (HP:0002617) | 2.18588372 |
| 67 | Gingivitis (HP:0000230) | 2.17566184 |
| 68 | Muscle fiber splitting (HP:0003555) | 2.17353000 |
| 69 | Abnormality of the thoracic spine (HP:0100711) | 2.16514036 |
| 70 | Turricephaly (HP:0000262) | 2.15830196 |
| 71 | Mitral regurgitation (HP:0001653) | 2.14625424 |
| 72 | Gout (HP:0001997) | 2.14595188 |
| 73 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.14592275 |
| 74 | Biconcave vertebral bodies (HP:0004586) | 2.13901855 |
| 75 | Reticulocytosis (HP:0001923) | 2.13896739 |
| 76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13298302 |
| 77 | Obstructive lung disease (HP:0006536) | 2.13298302 |
| 78 | Type 1 muscle fiber predominance (HP:0003803) | 2.12028323 |
| 79 | Nuclear cataract (HP:0100018) | 2.10736873 |
| 80 | Abnormality of the fingertips (HP:0001211) | 2.09924784 |
| 81 | Epidermoid cyst (HP:0200040) | 2.09435938 |
| 82 | Hypolipoproteinemia (HP:0010981) | 2.09364964 |
| 83 | Peritonitis (HP:0002586) | 2.07915890 |
| 84 | Spastic diplegia (HP:0001264) | 2.07190558 |
| 85 | Long toe (HP:0010511) | 2.06903857 |
| 86 | Hypobetalipoproteinemia (HP:0003563) | 2.05406611 |
| 87 | Polygenic inheritance (HP:0010982) | 2.04504505 |
| 88 | Distal lower limb muscle weakness (HP:0009053) | 2.04409380 |
| 89 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.03237827 |
| 90 | Hypoglycemic coma (HP:0001325) | 2.02007014 |
| 91 | Flat acetabular roof (HP:0003180) | 2.01987197 |
| 92 | Hand muscle atrophy (HP:0009130) | 2.01534043 |
| 93 | Axonal loss (HP:0003447) | 2.00887423 |
| 94 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.00204761 |
| 95 | Increased variability in muscle fiber diameter (HP:0003557) | 1.99086399 |
| 96 | Hypercholesterolemia (HP:0003124) | 1.98901265 |
| 97 | Neurofibrillary tangles (HP:0002185) | 1.98651286 |
| 98 | Thoracic kyphosis (HP:0002942) | 1.98405830 |
| 99 | Metaphyseal cupping (HP:0003021) | 1.98125242 |
| 100 | Exercise-induced muscle cramps (HP:0003710) | 1.97915718 |
| 101 | Myositis (HP:0100614) | 1.97538738 |
| 102 | Late onset (HP:0003584) | 1.97426343 |
| 103 | Ventricular tachycardia (HP:0004756) | 1.96998878 |
| 104 | Cholelithiasis (HP:0001081) | 1.96549120 |
| 105 | Joint stiffness (HP:0001387) | 1.96500416 |
| 106 | Mediastinal lymphadenopathy (HP:0100721) | 1.95993357 |
| 107 | Abnormality of the nasal mucosa (HP:0000433) | 1.95752624 |
| 108 | Interstitial pulmonary disease (HP:0006530) | 1.95655851 |
| 109 | Joint hemorrhage (HP:0005261) | 1.95601850 |
| 110 | Neonatal onset (HP:0003623) | 1.95431145 |
| 111 | Increased cerebral lipofuscin (HP:0011813) | 1.94512888 |
| 112 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.93147022 |
| 113 | Easy fatigability (HP:0003388) | 1.92717870 |
| 114 | Gastrointestinal stroma tumor (HP:0100723) | 1.92549930 |
| 115 | Long palpebral fissure (HP:0000637) | 1.92103657 |
| 116 | Inflammation of the large intestine (HP:0002037) | 1.91733287 |
| 117 | Ulnar bowing (HP:0003031) | 1.90990414 |
| 118 | Abnormality of the common coagulation pathway (HP:0010990) | 1.90272272 |
| 119 | Hypertriglyceridemia (HP:0002155) | 1.88636458 |
| 120 | Supranuclear gaze palsy (HP:0000605) | 1.88610543 |
| 121 | Fragile skin (HP:0001030) | 1.88023550 |
| 122 | Cerebral inclusion bodies (HP:0100314) | 1.87692300 |
| 123 | Abnormality of the lower motor neuron (HP:0002366) | 1.87184545 |
| 124 | Loss of speech (HP:0002371) | 1.86589723 |
| 125 | Rectal prolapse (HP:0002035) | 1.86330107 |
| 126 | Hemorrhage of the eye (HP:0011885) | 1.85925364 |
| 127 | Hypertensive crisis (HP:0100735) | 1.85766527 |
| 128 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.85604256 |
| 129 | Atrioventricular block (HP:0001678) | 1.84338307 |
| 130 | Neuronal loss in central nervous system (HP:0002529) | 1.83461093 |
| 131 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.83253761 |
| 132 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.83253761 |
| 133 | Abnormality of glycolipid metabolism (HP:0010969) | 1.83253761 |
| 134 | Nasal polyposis (HP:0100582) | 1.82526652 |
| 135 | Skin nodule (HP:0200036) | 1.82398184 |
| 136 | Bundle branch block (HP:0011710) | 1.82351951 |
| 137 | Malnutrition (HP:0004395) | 1.81957368 |
| 138 | Mitral stenosis (HP:0001718) | 1.81601328 |
| 139 | Hepatocellular carcinoma (HP:0001402) | 1.81238820 |
| 140 | Gastrointestinal infarctions (HP:0005244) | 1.79960257 |
| 141 | Frequent falls (HP:0002359) | 1.79954919 |
| 142 | Dysmetric saccades (HP:0000641) | 1.79269929 |
| 143 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.78597457 |
| 144 | Esophageal varix (HP:0002040) | 1.78510346 |
| 145 | Disproportionate tall stature (HP:0001519) | 1.78235415 |
| 146 | Rhabdomyolysis (HP:0003201) | 1.78172054 |
| 147 | Thin bony cortex (HP:0002753) | 1.77864520 |
| 148 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.77698072 |
| 149 | Blue sclerae (HP:0000592) | 1.77245167 |
| 150 | Atrophic scars (HP:0001075) | 1.74942228 |
| 151 | Abnormality of purine metabolism (HP:0004352) | 1.74887004 |
| 152 | Hyperglycinemia (HP:0002154) | 1.74592092 |
| 153 | Meningitis (HP:0001287) | 1.74128629 |
| 154 | Abnormal cartilage morphology (HP:0002763) | 1.73120777 |
| 155 | Atelectasis (HP:0100750) | 1.71346468 |
| 156 | Pseudobulbar signs (HP:0002200) | 1.71339383 |
| 157 | Mesangial abnormality (HP:0001966) | 1.71221842 |
| 158 | Pustule (HP:0200039) | 1.70399293 |
| 159 | Aortic aneurysm (HP:0004942) | 1.70317540 |
| 160 | Annular pancreas (HP:0001734) | 1.70291671 |
| 161 | Round ear (HP:0100830) | 1.69324076 |
| 162 | Myopathic facies (HP:0002058) | 1.69102646 |
| 163 | Purpura (HP:0000979) | 1.68926608 |
| 164 | Abnormal gallbladder morphology (HP:0012437) | 1.68475574 |
| 165 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.68011377 |
| 166 | Lower limb amyotrophy (HP:0007210) | 1.67811085 |
| 167 | Ankle contracture (HP:0006466) | 1.67637160 |
| 168 | Dilatation of the ascending aorta (HP:0005111) | 1.67599798 |
| 169 | Insomnia (HP:0100785) | 1.66485657 |
| 170 | Spontaneous hematomas (HP:0007420) | 1.65962170 |
| 171 | Impaired platelet aggregation (HP:0003540) | 1.65780743 |
| 172 | Abnormal platelet function (HP:0011869) | 1.65780743 |
| 173 | Onion bulb formation (HP:0003383) | 1.63371715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.31299812 |
| 2 | PKN2 | 4.09958154 |
| 3 | ERN1 | 3.38580766 |
| 4 | PRPF4B | 3.36231868 |
| 5 | EEF2K | 3.00985346 |
| 6 | MAP3K10 | 2.88463354 |
| 7 | SMG1 | 2.85950787 |
| 8 | TTN | 2.80175385 |
| 9 | SIK1 | 2.49941400 |
| 10 | RIPK1 | 2.02636920 |
| 11 | PTK6 | 1.99120022 |
| 12 | ICK | 1.97303543 |
| 13 | BCKDK | 1.93873246 |
| 14 | FGFR4 | 1.92406410 |
| 15 | IRAK3 | 1.86672526 |
| 16 | MAP3K13 | 1.83288276 |
| 17 | MAP4K1 | 1.79942196 |
| 18 | RIPK4 | 1.78466957 |
| 19 | TAOK1 | 1.76062641 |
| 20 | EPHB1 | 1.54843741 |
| 21 | MAP3K7 | 1.51943887 |
| 22 | PDGFRA | 1.51571230 |
| 23 | BMX | 1.45310520 |
| 24 | LRRK2 | 1.42944848 |
| 25 | NME2 | 1.42913043 |
| 26 | TNK2 | 1.42188508 |
| 27 | CDK12 | 1.31008780 |
| 28 | DMPK | 1.29937288 |
| 29 | MAP2K3 | 1.22429458 |
| 30 | TAOK2 | 1.11747365 |
| 31 | GRK6 | 1.09674408 |
| 32 | SIK3 | 1.09524886 |
| 33 | IRAK4 | 1.09454783 |
| 34 | MAP3K14 | 1.08400554 |
| 35 | MST1R | 1.04809265 |
| 36 | MTOR | 1.02530339 |
| 37 | SIK2 | 1.01755923 |
| 38 | MAP3K6 | 0.99853824 |
| 39 | ALK | 0.99793553 |
| 40 | DDR2 | 0.98965626 |
| 41 | TGFBR2 | 0.98412031 |
| 42 | EPHA2 | 0.97598430 |
| 43 | PRKD3 | 0.95836174 |
| 44 | CAMK1D | 0.95681672 |
| 45 | LMTK2 | 0.94479863 |
| 46 | CAMK1G | 0.93761608 |
| 47 | TYRO3 | 0.93131476 |
| 48 | PRKD2 | 0.92842399 |
| 49 | PTK2 | 0.91568902 |
| 50 | MAP3K11 | 0.87470482 |
| 51 | KSR2 | 0.87328040 |
| 52 | PRKCH | 0.86424890 |
| 53 | HIPK2 | 0.86394707 |
| 54 | PAK2 | 0.85355785 |
| 55 | LATS1 | 0.84588418 |
| 56 | FLT3 | 0.84103698 |
| 57 | FES | 0.83758120 |
| 58 | TESK1 | 0.83687061 |
| 59 | PAK4 | 0.83451725 |
| 60 | TYK2 | 0.82095734 |
| 61 | RET | 0.81172334 |
| 62 | STK38 | 0.81150864 |
| 63 | ZAP70 | 0.80422881 |
| 64 | DYRK1B | 0.79270752 |
| 65 | PHKG1 | 0.79103392 |
| 66 | PHKG2 | 0.79103392 |
| 67 | JAK1 | 0.77694361 |
| 68 | PRKD1 | 0.75718809 |
| 69 | MAPK11 | 0.74705637 |
| 70 | CDK6 | 0.74646322 |
| 71 | CSK | 0.74479721 |
| 72 | TBK1 | 0.74425159 |
| 73 | JAK2 | 0.73784109 |
| 74 | PDPK1 | 0.71839558 |
| 75 | ARAF | 0.69086289 |
| 76 | MAP2K2 | 0.68626750 |
| 77 | KDR | 0.66356279 |
| 78 | ILK | 0.65376116 |
| 79 | IRAK2 | 0.65236299 |
| 80 | MARK2 | 0.64395889 |
| 81 | MAPK7 | 0.64138703 |
| 82 | STK10 | 0.63738640 |
| 83 | SCYL2 | 0.63545940 |
| 84 | MAP2K6 | 0.63383209 |
| 85 | CAMKK1 | 0.63320480 |
| 86 | CDK4 | 0.62560590 |
| 87 | MAPK15 | 0.60555131 |
| 88 | HCK | 0.60369960 |
| 89 | PDK4 | 0.59856788 |
| 90 | PDK3 | 0.59856788 |
| 91 | PDK1 | 0.59571822 |
| 92 | DAPK3 | 0.59226797 |
| 93 | PAK6 | 0.58425597 |
| 94 | PDGFRB | 0.57687924 |
| 95 | IKBKE | 0.57122616 |
| 96 | MAP3K8 | 0.57090140 |
| 97 | STK11 | 0.55252188 |
| 98 | BLK | 0.54371403 |
| 99 | MAP3K1 | 0.52966294 |
| 100 | MAPK12 | 0.52921760 |
| 101 | PRKAA2 | 0.51825073 |
| 102 | TAOK3 | 0.51312245 |
| 103 | TESK2 | 0.50778163 |
| 104 | FGFR3 | 0.49820540 |
| 105 | NEK1 | 0.49023895 |
| 106 | DAPK2 | 0.48567023 |
| 107 | RPS6KA1 | 0.48358138 |
| 108 | RPS6KA2 | 0.46745627 |
| 109 | MAP3K3 | 0.46214656 |
| 110 | ITK | 0.45386561 |
| 111 | NEK2 | 0.45035707 |
| 112 | LATS2 | 0.44875793 |
| 113 | NTRK1 | 0.44005389 |
| 114 | MAP3K2 | 0.42982360 |
| 115 | MAPKAPK3 | 0.42644400 |
| 116 | WNK4 | 0.42333345 |
| 117 | CDC42BPA | 0.40884652 |
| 118 | FGR | 0.40469497 |
| 119 | LCK | 0.40181267 |
| 120 | IKBKB | 0.40163230 |
| 121 | BRAF | 0.40066696 |
| 122 | GSK3A | 0.39825237 |
| 123 | RPS6KL1 | 0.39525081 |
| 124 | RPS6KC1 | 0.39525081 |
| 125 | PRKAA1 | 0.39426458 |
| 126 | BTK | 0.38603371 |
| 127 | MAPK4 | 0.38562162 |
| 128 | RPS6KA6 | 0.38213197 |
| 129 | JAK3 | 0.37756576 |
| 130 | SYK | 0.37397102 |
| 131 | SGK3 | 0.37360100 |
| 132 | PRKG2 | 0.35868343 |
| 133 | CSF1R | 0.35703206 |
| 134 | MOS | 0.34268794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.71087645 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35533752 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.22865392 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.84916019 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.69913334 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55853734 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.52198503 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.35371558 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.29259273 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.08866104 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.01211225 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.98273325 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86699875 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.77942218 |
| 15 | Bile secretion_Homo sapiens_hsa04976 | 1.77046005 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76399340 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.73165264 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.70373303 |
| 19 | Lysine degradation_Homo sapiens_hsa00310 | 1.69398905 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.69233924 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.61823808 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.57871933 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.56520052 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45654284 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.43563590 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.42751029 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.42311825 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.29823351 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.29464913 |
| 30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.29173705 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27708284 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26399829 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.24549842 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.24416066 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.24383671 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.22572976 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21355830 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20125614 |
| 39 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.19669027 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.19048205 |
| 41 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.18168507 |
| 42 | Insulin resistance_Homo sapiens_hsa04931 | 1.17925820 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17815766 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16298482 |
| 45 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.13975778 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.13975207 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.13751353 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 1.11671904 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11412891 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 1.10768238 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.10201724 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 1.10082694 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 1.05944301 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.01920492 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 1.01425110 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01117942 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00886495 |
| 58 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.96937670 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95487909 |
| 60 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.95209808 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.94805818 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94677818 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.93810397 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93667222 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93051889 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92057155 |
| 67 | Allograft rejection_Homo sapiens_hsa05330 | 0.91011692 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 0.90506027 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90186680 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89802682 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.88899883 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.88400545 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88144370 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86437233 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84390969 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83966489 |
| 77 | Measles_Homo sapiens_hsa05162 | 0.83850383 |
| 78 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.82115007 |
| 79 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.81767299 |
| 80 | Malaria_Homo sapiens_hsa05144 | 0.81151256 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.81091376 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81001482 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.80519990 |
| 84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79428920 |
| 85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79415197 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76131345 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.75741887 |
| 88 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74844156 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74666881 |
| 90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74161339 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73761329 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.72103032 |
| 93 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71450280 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.71037888 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70975835 |
| 96 | Shigellosis_Homo sapiens_hsa05131 | 0.69066815 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68810663 |
| 98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68747910 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67851513 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67445902 |
| 101 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66765522 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.66186805 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66172220 |
| 104 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65983735 |
| 105 | Focal adhesion_Homo sapiens_hsa04510 | 0.65841661 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65772480 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64265582 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64000734 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62052419 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61573278 |
| 111 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.61057977 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.61046610 |
| 113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60741193 |
| 114 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60659622 |
| 115 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60574017 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60430783 |
| 117 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59965212 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59403055 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59272832 |
| 120 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58013739 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57919765 |
| 122 | Long-term potentiation_Homo sapiens_hsa04720 | 0.57277867 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56865322 |
| 124 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56278238 |
| 125 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55992709 |
| 126 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54434790 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54051264 |
| 128 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53778482 |
| 129 | Prion diseases_Homo sapiens_hsa05020 | 0.53691770 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49463239 |
| 131 | Glioma_Homo sapiens_hsa05214 | 0.48742398 |
| 132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47972633 |
| 133 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47945125 |
| 134 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47177070 |
| 135 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46805962 |
| 136 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46422531 |
| 137 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46422382 |
| 138 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45914201 |
| 139 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45903539 |
| 140 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.45394276 |
| 141 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.44056423 |
| 142 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41632513 |
| 143 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38824087 |
| 144 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37892093 |
| 145 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37848020 |
| 146 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.37524857 |
| 147 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.37226228 |
| 148 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35856481 |
| 149 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.35212864 |
| 150 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35065507 |
| 151 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34666907 |
| 152 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34543057 |
| 153 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34519872 |
| 154 | Platelet activation_Homo sapiens_hsa04611 | 0.34464467 |
| 155 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.34325617 |
| 156 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34100344 |
| 157 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34099008 |
| 158 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33469626 |

